Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| AV-G-02 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhinoconjunctivitis with or without asthma.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Avanz Phleum pratense 15,000 SQ+ | Active Comparator |
| |
| Avanz Phleum pratense 4,000 SQ+ | Active Comparator |
| |
| Injection with no active grass component | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Avanz Phleum pratense | Drug | Suspension for Injection, Every 6 weeks for one year |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recording of rhinoconjunctivitis symptoms | Daily recordings during the grass pollen season 2012 | |
| Recording of symptomatic allergy medication use | Daily recordings during the grass pollen seasons 2012 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jörg Kleine-Tebbe, PD Dr. | Clinical Research Center for Dermatology, Allergy and Asthma | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UntersuchungsZentrum für Dermatologie, Allergologie und Asthma | Berlin | State of Berlin | 14050 | Germany |
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Suspension for Injection, Every 6 weeks for one year |
|